scFv proteins: key engineered antibody fragments from molecular structure to disease diagnosis and therapeutic applications

Author: Senior Product Manager of UA Views：4

This article focuses on the molecular characteristics and biological functions of single-chain antibody fragments (scFv), systematically elaborating on their structural basis of assembly from antibody heavy-chain variable regions and light-chain variable regions connected by peptide linkers, analyzing the assembly strategies and affinity advantages of multivalent forms such as scFv monomers, tandem antibodies, diabodies, and trimers, and exploring the preparation process and purification strategies for screening high-affinity scFv using phage display technology.

Recent Advances
Product Information

Recent Advances

scFv Proteins: Key Engineered Antibody Fragments from Molecular Structure to Disease Diagnosis and Treatment Applications

Brief Introduction: This article focuses on the molecular characteristics and biological functions of single-chain antibody fragments (scFv), systematically elaborating on the structural basis of their assembly from antibody heavy-chain variable regions and light-chain variable regions connected by linker peptides, analyzing the assembly strategies and affinity advantages of multivalent forms such as scFv monomers, tandem antibodies, diabodies, and trimers, and discussing the preparation process for screening high-affinity scFv using phage display technology as well as their purification strategies.

I. Molecular Structural Basis of scFv and Linker Peptide Design.

A complete antibody consists of two heavy chains and two light chains. Through artificial engineering, it can be made to express only the variable regions. A single-chain antibody is a small molecule composed of the variable region of an antibody heavy chain and the variable region of a light chain connected by a peptide chain, and is the smallest functional structural unit with antibody activity. Specifically, a recombinantly synthesized linker peptide gene is used to connect the antibody heavy-chain variable region and light-chain variable region into a recombinant gene, and the antibody expressed from this recombinant gene is called a single-chain antibody. Structurally, the N-terminus of the heavy chain can be connected to the C-terminus of the light chain, or the N-terminus of the light chain can be connected to the C-terminus of the heavy chain; both connection orientations can form a functional scFv.

The length of the linker peptide is usually 15 to 25 amino acids, typically composed of glycine and serine, and possesses a certain degree of flexibility and protease resistance. The role of the linker peptide is to connect the heavy-chain variable region and the light-chain variable region and maintain a certain flexibility so that the functional domains of the two variable regions can still pair after folding, forming a monovalent antigen-binding site. Glycine provides flexibility and spatial freedom, while serine confers water solubility and protease resistance to the linker peptide. This combination enables the linker peptide to both maintain the correct spatial orientation of the two variable regions and avoid interfering with the folding of the variable regions. The length and sequence design of the linker peptide are key parameters determining the stability and antigen-binding activity of scFv.

II. Assembly Strategies and Affinity Advantages of Multivalent scFv Forms.

The scFv fragment is monovalent, and a bivalent scFv can be produced by connecting two scFv fragments. Bivalent scFv generally has two structures: one is a single peptide chain containing two heavy-chain variable regions and two light-chain variable regions, called a tandem antibody; the other is to shorten the linker peptide length from 15 to 3 to 12, allowing the heavy-chain variable region and light-chain variable region functional domains from two different molecules to pair with each other, forming a dimeric structure called a diabody. If the diabody is composed of variable regions from two different antigens, a bispecific antibody will be formed. Similarly, a tandem antibody with three heavy-chain variable regions and three light-chain variable regions can be produced, or by further shortening the linker peptide length, the variable region functional domains from three different molecules can pair with each other to form a trimer. Compared with ordinary scFv fragments, scFv multimers have an increased antigen-binding valence and higher affinity. This strategy of regulating the multimerization state through linker peptide length provides a simple and flexible molecular design tool for the affinity engineering of scFv.

III. Preparation of scFv and Screening of High-Affinity Fragments.

scFv can be expressed in multiple expression systems, with the currently more commonly used ones being the Escherichia coli expression system and the mammalian expression system. scFv fragments can also be produced through phage display technology. Hybridoma cells are obtained through immunization animal experiments, cDNA is extracted from them, reverse transcription PCR is used to obtain the full set of antibody heavy-chain variable regions and light-chain variable regions, and overlap PCR is used to splice and amplify the heavy-chain and light-chain variable region fragments to obtain single-chain antibody variable region gene fragments. The scFv gene is cloned into a suitable phage vector, electroporated into competent Escherichia coli, superinfected with helper phage, and the resulting supernatant is the single-chain antibody library. Using a specific antigen as the solid phase, after 3 to 5 rounds of "adsorption-elution-amplification" screening, enriched single-chain antibodies capable of specifically binding to the antigen can be obtained. The core advantage of phage display technology lies in directly coupling genotype and phenotype through phage particles, enabling high-affinity clones to be efficiently enriched through multiple rounds of affinity selection.

IV. Purification Strategies for scFv.

Single-chain antibodies lack the Fc fragment contained in intact antibodies, so ordinary binding sites cannot be used to purify the antibodies. Usually, 6 histidines are added to the C-terminus of the scFv fragment, and then metal chelate affinity chromatography can be used to purify the single-chain antibody. In addition, protein L can interact with the variable region of the light chain, so protein L can also be used for antibody purification. Certain special scFv fragments can also be captured and purified by protein A, but the underlying principle remains unknown. For scFv with a His tag, metal chelate affinity chromatography is the preferred purification strategy, as it is simple to operate, cost-controllable, and has mild elution conditions, which is conducive to maintaining the antigen-binding activity of scFv.

V. Applications of scFv in Targeted Therapy, Imaging Diagnosis, and Biological Detection.

scFv has advantages such as small molecular mass, strong penetration, and relatively high specificity, and has important applications in targeted therapy, imaging diagnosis, intracellular immunity, biological detection, and other areas. In targeted therapy, drugs and toxins can be linked to scFv to form immunodrugs or immunotoxins, utilizing the characteristics of specific antigen-antibody binding to localize to target cells and carry out specific immune killing of target cells. In imaging diagnosis, because scFv has strong penetration, its distribution index in tumor tissue is higher than that of intact antibody molecules; during radionuclide imaging, radionuclides are excreted quickly, causing less harm to the body, and it can be used for tumor imaging localization diagnosis. In intracellular immunity, after a virus infects an organism, antibodies that can recognize a certain viral encoded protein are expressed intracellularly, thereby preventing the virus from spreading between cells. Single-chain antibodies against antiviral proteins can be cloned and expressed intracellularly, and can thus be used for the diagnosis and treatment of viral infectious diseases. In biological detection, scFv has good affinity and is easy to prepare, so it is used to quickly and accurately detect harmful substances in food, water, and other materials. In addition, the characteristics of scFv, such as small molecular mass, short half-life, and low immunogenicity, give it broad application prospects in clinical diagnosis, treatment, and prevention.

VI. Conclusion.

In basic research and application development related to scFv, high-quality recombinant scFv protein is a core tool for analyzing its antigen-binding characteristics, evaluating targeting delivery efficiency, and developing immunotherapeutic strategies. The His tag facilitates purification by immobilized metal affinity chromatography and enables detection and capture by anti-His tag antibodies. To meet the needs of scFv functional research and targeted therapy strategy exploration, Ulove provides Leu16 scfv His Tag Protein. This product is suitable for application scenarios such as binding activity analysis of scFv with target antigens, scFv-mediated targeted delivery and immunotoxin research, application development of scFv in tumor imaging diagnosis and biological detection, and mechanistic research on multivalent forms and affinity engineering of scFv.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next